Back to mobile site
Get it on Google Play

Nasus Pharma to present NS002 intranasal epinephrine study results

March 9, 2026 8:30 AM EDT Send to a Friend
Nasus Pharma Ltd. (NYSE: NSRX) announced it will host a conference call on March 16, 2026, at 8:00 a.m. ET ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login